Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes

Journal of the American Academy of Dermatology

Volumn 46, Issue 5, 2002, Pages 661-666

  Su, Lyndon D ^a   Lowe, Lori ^a   Bradford, Carol R ^a   Yahanda, Alan I ^a   Johnson, Timothy M ^a   Sondak, Vernon K ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHROMOGRANIN A; CYTOKERATIN 20; EOSIN; HEMATOXYLIN; NEUROFILAMENT PROTEIN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION;

EID: 0036587277     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.119563     Document Type: Article

References (32)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105:107-10.
2. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultra-structural study. Cancer 1978;42:2311-21.
3. Shaw JHF, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991;78:138-42.
4. Raaf JH, Urmacher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin: treatment of primary, recurrent, and metastatic disease. Cancer 1986;57:178-82.
5. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma: prognosis and management. Arch Surg 1991;126:1514-9.
6. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97-105.
7. Hitchcock CL, Bland KI, Laney RG, Franzini D, Harris B, Copeland EM. Neuroendocrine (Merkel cell) carcinoma of the skin: its natural history, diagnosis, and treatment. Ann Surg 1988;207:201-7.
8. Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 2000; 26:12-8.
9. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
10. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996;5:33-41.
11. Ames SE, Krag DN, Brady MS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998;67:251-4.
12. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
13. DeCicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000;82:295-9.
14. Giuliano AK, Kirgen DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
15. Hill ADK, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518-21.
16. Kelemen PR, van Herle AJ, Giuliano AK. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288-92.
17. Koops HS, Doting MH, de Vries J, Tiebosch AT, Plukker JT, Hoekstra HJ, et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol 1999;51:1-7.
18. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389-95.
19. Pfeifer T, Weinberg H, Brady MS. Lymphatic mapping for Merkel cell carcinoma. J Am Acad Dermatol 1997;37:650-1.
20. Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ. Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg 1999;42:679-82.
21. Wasserberg N, Feinmesser M, Schachter J, Fenig E, Gutman H. Sentinel-node guided lymph-node dissection for Merkel cell carcinoma. Eur J Surg Oncol 1999;25:444-6.
22. O'Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, PetersenSchaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461-6.
23. Glass FL, Cottam JA, Reintgen DS, Fenske NA. Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol 1998;39:603-10.
24. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
25. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-83.
26. Schmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol 1998;20:346-51.
27. Yu LL, Flotte JJ, Tanabe KK, Gadd MA, Cosimi AB, Sober AJ, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617-27.
28. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-34.
29. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-8.
30. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999;21:16-20.
31. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-40.
32. Xu X, Roberts SA, Pasha TL, Zhang PJ. Undesirable cytokeratin immunoreactivity of native non-epithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000;124:1310-3.